Penumbra, Inc. develops clinically beneficial products that help patients suffering from stroke and other neurovascular diseases. It offers Penumbra System, an ischemic stroke device platform; Penumbra Coil 400 that allows rapid packing of aneurysms; 5MAX ACE, a clot extraction device for engaging and removing blood clots causing an acute ischemic stroke; and Neuron System, a family of access catheters to enable therapies to be delivered to blood vessels high up in the brain. The company sells its products in North and South America, Europe, Australia, and Asia. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.